Learn more about ARM's 3rd Annual Regen Med Investor Day - March 25, 2015 in New York! Don't miss the only financing event organized specifically for the advanced therapies sector providing institutional, strategic and venture investors with unique insight into the top regen med and advanced therapies companies.

Find out more about our Tech Sections - Cell Therapy, Gene & Gene-Modified Cell Therapy and Tissue Engineering & Biomaterials - created to ensure these major technology constituencies within ARM's membership are given a primary voice within the organization.

Advance your organization through participation in ARM. Join our 200+ members worldwide in supporting effective regenerative medicine and advanced therapy policies and connect with key partners and potential investors committed to this sector. 

About ARM

Advancing Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations.
Learn more

Our Members

200+ and Growing
ARM’s membership is diverse, representing leading regenerative medicine companies and investors, university-based and non-profit research institutions, patient advocacy groups, pharmaceutical companies engaged in regenerative medicine research and other organizations supporting regenerative medicine.
Learn more